Wellbutrin SR generic dispute
Executive Summary
GlaxoSmithKline's temporary restraining order barring Eon from distributing extended-release bupropion (Wellbutrin SR) extended to Dec. 22 by New York federal court. Eon and Andrx disagree on whether a Florida magistrate's recommendation that a TRO issue is currently in effect (1"The Pink Sheet" Dec. 8, 2003, p. 25)...
You may also be interested in...
Eon Wellbutrin SR Generic Launch Delayed By Two Restraining Orders
Eon's launch of generic bupropion extended-release 100 mg (GlaxoSmithKline's Wellbutrin SR) depends on the resolution of two temporary restraining orders: one from GSK and one from Andrx
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.